News | November 28, 2025
GV20 Therapeutics hits milestone in AI-driven cancer therapy collaboration with Mitsubishi Tanabe Pharma
GV20 received an upfront payment and is eligible for additional milestone payments
GV20 received an upfront payment and is eligible for additional milestone payments
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Subscribe To Our Newsletter & Stay Updated
